Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
about
Interactions between HLA-G and HLA-E in Physiological and Pathological ConditionsNatural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodiesIdentification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating moleculeGalectin-9 functionally impairs natural killer cells in humans and miceEffects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30)Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation.Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding siteClinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signalingHuman T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite thHuman dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cellsNTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative diseaseTransforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cellsNatural killer cells and autoimmunityRecognition and Regulation of T Cells by NK CellsNutritional immunology: function of natural killer cells and their modulation by resveratrol for cancer prevention and treatmentAvian Influenza Viruses, Inflammation, and CD8(+) T Cell ImmunityCord Blood as a Source of Natural Killer CellsNatural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer ImmunotherapyEffector Functions of Natural Killer Cell Subsets in the Control of Hematological MalignanciesCD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor ActivityMyeloid suppressor cells and immune modulation in lung cancerNatural killer cell biology: an update and future directionsDeciphering the transcriptional switches of innate lymphoid cell programming: the right factors at the right timeNK Cell Inflammation in the Clinical Outcome of Colorectal CarcinomaEmerging concepts in immunity to hepatitis C virus infection.The role of natural cytotoxicity receptors in various pathologies: emphasis on type I diabetesNatural Killer Receptor 1 Dampens the Development of Allergic Eosinophilic Airway InflammationPhenotypic and Functional Changes of Cytotoxic CD56pos Natural T Cells Determine Outcome of Acute Hepatitis C Virus InfectionNKp44 Receptor Mediates Interaction of the Envelope Glycoproteins from the West Nile and Dengue Viruses with NK CellsCrystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptorsHuman NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 ReceptorMesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor MicroenvironmentFeatures of Memory-Like and PD-1(+) Human NK Cell SubsetsCrosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor MicroenvironmentImmunological and Translational Aspects of NK Cell-Based Antitumor ImmunotherapiesNKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathwayAssociation of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinaseHuman natural killer cell receptors: insights into their molecular function and structureCCL21 Chemokine Therapy for Lung Cancer.Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4)
P2860
Q21131161-1D3A1EFC-DE98-49EF-9851-4AD57FBB6C1BQ21131216-F8E64C01-17D6-4755-B00B-BB39E165ECF1Q24314704-05F7423A-D4FE-4CFC-BAE1-ED25E52F8B54Q24317152-A1BF8719-02D0-42F7-A6EE-67EFE907B75CQ24338325-563F0BD4-B149-4DF8-925D-9C63AFC8F5ADQ24536121-4B0B8366-FCCF-41F0-9EFD-DCC5CC35F481Q24615889-3ABB4331-9DEF-45AF-98DB-F3B67DEF8880Q24649116-0FC1931D-EB6B-45B7-9D58-DBFB9B6F1D6FQ24671809-A8B85091-D509-4FA6-B243-6B9DC1A0D117Q24675226-165CA8B6-5D75-4A2A-8A38-2AA027E75A1BQ24675566-A3DE4503-81C5-4B74-A1DD-9019E77892EAQ24683311-040F58BD-F0F6-403A-83FF-2F5CDF3DB3CCQ24793284-F268ED20-F94C-4EC5-A577-ACEFAA939D31Q26742166-604E8291-B822-4419-807A-904A1E52317AQ26753067-87D79E68-992F-456C-8292-BB3508CA6843Q26765927-E2AEAE9C-54A8-4109-8911-CBF1FBA83EF8Q26771337-2F8491C1-38A4-420C-B0A3-23A33DB0BB38Q26772347-8308DDF8-36A6-4F2B-B557-D2F7F8E1FAF2Q26776538-1F175BEA-AF47-4484-B6B3-82107C9258F0Q26782520-7CA2EB88-DDAF-4480-82FD-4FEAAC51415FQ26823251-C7CA5E0A-2FB0-4E1C-9B80-B6EB580D7219Q26830512-2AA20B20-8575-4FAD-A4A7-C3F7E90D984FQ26861554-36A5E5EC-B550-47AC-90B6-F15E7274043EQ26991949-727CEE8B-2949-4AC4-A139-4B134FF9B681Q27002588-1A2A74F1-1375-4EFB-93E7-4B3F651B34BEQ27003384-5A4626A4-AE4B-4D8C-BB15-732064892211Q27330062-E2183B9C-2A86-4F82-8B65-1A97FCC47BC4Q27481031-23270D15-050A-43FB-8A59-FF59F38B87EBQ27490238-8656FC26-BD78-4C38-A8A4-FAF1BABD0C74Q27641970-9E0E79AA-2ED0-43FA-B200-4A11761D0A06Q28067468-C326EC54-9B68-42A0-B262-2830D87F3ECFQ28073613-84A38F17-7061-4D36-A23B-1225DCAC1212Q28073988-ECC14926-CD0E-4C8B-A979-777EAD46F10EQ28077126-0ECF809D-267F-49D9-B742-840299BBBFDDQ28079180-EEBF888F-C340-410E-B9BC-10039C9475E5Q28203601-E292D9BB-3B69-4BCA-9AD8-323DAD963F8CQ28216840-17801571-8C8A-4D38-B7FA-4F36D9D5EC70Q28241698-B6C05B0B-DF5C-46E8-9B1D-843EAFE1C71AQ28248811-C6ED4785-A078-4BC3-975F-0F0978BC37E9Q28271106-428AFD85-855A-4D47-BF44-DABFA2C8C0B2
P2860
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Activating receptors and corec ...... iller cell-mediated cytolysis.
@ast
Activating receptors and corec ...... iller cell-mediated cytolysis.
@en
Activating receptors and corec ...... iller cell-mediated cytolysis.
@nl
type
label
Activating receptors and corec ...... iller cell-mediated cytolysis.
@ast
Activating receptors and corec ...... iller cell-mediated cytolysis.
@en
Activating receptors and corec ...... iller cell-mediated cytolysis.
@nl
prefLabel
Activating receptors and corec ...... iller cell-mediated cytolysis.
@ast
Activating receptors and corec ...... iller cell-mediated cytolysis.
@en
Activating receptors and corec ...... iller cell-mediated cytolysis.
@nl
P2093
P50
P1476
Activating receptors and corec ...... killer cell-mediated cytolysis
@en
P2093
P304
P356
10.1146/ANNUREV.IMMUNOL.19.1.197
P577
2001-01-01T00:00:00Z